Quiz: Cancers Associated with Human Papillomavirus

Moving the needle in cancer research was an important focus for the journal ONCOLOGY in 2025.

Daniel C. McFarland, DO; and Michelle B. Riba, MD, spoke about distress screening and integrating psychosocial care into oncology.

Treatment with PT-112 appeared to be well-tolerated among those with recurrent thymoma in a phase 2 trial.

Experts share updated results on investigational hematologic oncology regimens that they presented at the 2025 ASH Meeting.

Safety data from ASCENT-03 support sacituzumab govitecan as an effective therapy with manageable toxicities in advanced triple-negative breast cancer.

Data from the phase 3 MANUEVER trial support the approval of pimicotinib for patients in China with symptomatic tenosynovial giant cell tumors.